Mesenkia Therapeutics AB
PrivateLast Round
VC Round
May 22, 2026
Total Funding Raised
$590,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mesenkia Therapeutics AB is a biotechnology company that develops biological drug candidates for the treatment of glioblastoma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mesenkia Therapeutics AB Comparables
Compare Mesenkia Therapeutics AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adaptin Bio | 81% | |
| Targepeutics | 79% | |
| Merck & Co., Inc. | 69% | |
Mesenkia Therapeutics AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 22, 2026 | ||||
| Seed | Jun 2, 2025 |
Mesenkia Therapeutics AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Almi Invest AB | Seed |
| Uppsala University Invest | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Grew 60% from 5 to 8 employees this quarter.
- May 22, 2026
Raised a VC Round with participation from lsi-zeta.
Mesenkia Therapeutics AB Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mesenkia Therapeutics AB's valuation, stock price, and market status.